PRESS RELEASE published on 10/04/2023 at 11:01, 2 years 6 months ago Original-Research: CR Energy AG (von GBC AG): Kaufen
PRESS RELEASE published on 07/06/2023 at 11:41, 2 years 9 months ago Original-Research: CR Capital AG (von First Berlin Equity Research GmbH): Kaufen
PRESS RELEASE published on 06/12/2023 at 08:01, 2 years 9 months ago Original-Research: CR Capital AG (von GBC AG): Kaufen
Published on 04/07/2026 at 15:00, 2 hours 26 minutes ago Karbon-X Expands Enterprise Climate Platform Through Strategic Partnership with carbon-connect AG
Published on 04/07/2026 at 14:45, 2 hours 41 minutes ago Predictiv AI Introduces Clinical AI Reasoning Platform, Files Patent for Domain-Specific Clinical AI Methodology
Published on 04/07/2026 at 14:40, 2 hours 46 minutes ago bioEnergy Development Inc. Advances Domestic Activated Carbon Production Worth Up to $30 Million Over 5 Years
Published on 04/07/2026 at 14:30, 2 hours 56 minutes ago Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides
Published on 04/07/2026 at 14:30, 2 hours 56 minutes ago Sekur Private Data Announces Philip Oakley and Kenneth Rogers as Members of Strategic Advisory Board
Published on 04/07/2026 at 16:32, 54 minutes ago Andera Partners portfolio company, Tubulis, acquired by Gilead, adding a potentially best-in-class antibody-drug conjugate and a next-generation platform to Gilead’s oncology pipeline.
Published on 04/07/2026 at 16:30, 56 minutes ago From Old Channel to New Garden: How Chaoyang’s 'Sakura River' is Dazzling Spring
Published on 04/07/2026 at 15:00, 2 hours 26 minutes ago Amrize Announces Date for First Quarter 2026 Financial Results
Published on 04/07/2026 at 14:55, 2 hours 31 minutes ago Original-Research: Delticom AG (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 04/07/2026 at 14:42, 2 hours 44 minutes ago Evotec to Receive Approx. $100 Million as Part of Tubulis Acquisition
Published on 04/07/2026 at 16:43, 43 minutes ago Exercice de l’option de remboursement de l'instrument subordonné FR0010318386
Published on 04/07/2026 at 16:43, 43 minutes ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010318386
Published on 04/07/2026 at 16:18, 1 hour 8 minutes ago NRJ Group - Information relative aux droits de vote au 31.03.2026 (French & English)
Published on 04/07/2026 at 14:44, 2 hours 42 minutes ago Statement of transactions in own shares from March 30, 2026 to April 2, 2026
